On April 15, 2022, Christoph Lengauer, a member of the board of directors of HOOKIPA Pharma Inc. notified the Company that he will not stand for re-election to the Board when his term expires at the Company's 2022 annual meeting of shareholders on June 30, 2022. Dr. Lengauer's decision not to stand for re-election to the Board is not due to any disagreement with the Company. Dr. Lengauer will continue to serve as a member of the Board and a member of the Nominating and Corporate Governance Committee of the Board until the 2022 Annual Meeting, when his resignation will be deemed effective.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7062 USD | -1.02% | -9.81% | -12.81% |
Jun. 05 | HC Wainwright Adjusts Price Target on HOOKIPA Pharma to $6 From $5, Maintains Buy Rating | MT |
Jun. 04 | Transcript : HOOKIPA Pharma Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.81% | 69.88M | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- HOOK Stock
- News HOOKIPA Pharma Inc.
- HOOKIPA Pharma Inc. Announces Christoph Lengauer, A Member of the Board of Directors Will Not Stand for Re-Election